Carisoprodol (CRM) (Synonyms: NIH 10966, NSC 172124) |
| Catalog No.GC45399 |
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 78-44-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Carisoprodol (CRM) is a certified reference material categorized as a skeletal muscle relaxant.1 It also has sedative properties.2 Carisoprodol is regulated as a Schedule IV compound in the United States. Carisoprodol (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
References
1. Reeves, R.R., Burke, R.S., and Kose, S. Carisoprodol: Update on abuse potential and legal status. South Med.J. 105, 619-623 (2012).
2. Gonzalez, L.A., Gatch, M.B., Taylor, C.M., et al. Carisoprodol-mediated modulation of GABAA receptors: In vitro and in vivo studies. J. Pharmacol. Exp. Ther. 329(2), 827-837 (2009).
Average Rating: 5 (Based on Reviews and 37 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *